FDA accepts NDA for mometasone furoate/formoterol fumarate combination for maintenance treatment of asthma - MPR
Links shared publicly online about this topic.
- 1,876total visits
FDA accepts NDA for mometasone furoate/formoterol fumarate combination for maintenance treatment of asthma - MPR
empr.com —
Schering-Plough announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed and accepted for review by the FDA for the maintenance treatment of asthma in patients 12 years of age.
View full resource at empr.com
Tags: Asthma, Drug, FDA, Nasonex, News
Most Recently Shared on July 23, 2009 at 4:08 pm By:
MPR News: FDA accepts NDA for mometasone furoate/formoterol fumarate combination for maintenance treatm.. http://bit.ly/17KDNW
Advertisement
